Functional analysis of HLA-DP polymorphism: A crucial role for DPβ residues 9, 11, 35, 55, 56, 69 and 84-87 in T cell allorecognition and peptide binding

International Immunology

Volumn 15, Issue 5, 2003, Pages 565-576

  Díaz, Gema ^a   Amicosante, Massimo ^b   Jaraquemada, Dolores ^c   Butler, Richard H ^d   Guillén, M Victoria ^a   Sánchez, Miguel ^a,e   Nombela, César ^a   Arroyo, Javier ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d CNR   (Italy)

^e Instituto de Biología Funcional y Genómica and Departamento de Microbiología y Genética   (Spain)

Author keywords

Allorecognition; HLA DP antigen; Molecular modeling; Peptide binding; Polymorphism; T cell

Indexed keywords

HLA DP ANTIGEN; LIGAND; MONOCLONAL ANTIBODY; T LYMPHOCYTE RECEPTOR;

AMINO ACID SUBSTITUTION; ANTIGEN FUNCTION; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ANTIGEN STRUCTURE; ARTICLE; CONFORMATION; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; LYMPHOCYTE CLONE; LYMPHOCYTE FUNCTION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR MODEL; PEPTIDE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN POLYMORPHISM; STRUCTURE ACTIVITY RELATION;

ANTIBODIES, MONOCLONAL; HLA-DP ANTIGENS; HUMANS; PEPTIDES; POLYMORPHISM, GENETIC; PROTEIN BINDING; STRUCTURE-ACTIVITY RELATIONSHIP; T-LYMPHOCYTES;

EID: 0242417045     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/dxg057     Document Type: Article

References (55)

1. Germain, R. N. 1994. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 76:287.
2. Stern, L. J., Brown, J. H., Jardetzky, T. S., Gorga, J. C., Urban, R. G., Strominger, J. L. and Wiley, D. C. 1994. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368:215.
3. Jardetzky, T. S., Brown, J. H., Gorga, J. C., Stern, L. J., Urban, R. G., Strominger, J. L. and Wiley, D. C. 1996. Crystallographic analysis of endogenous peptides associated with HLA-DR1 suggests a common, polyproline II-like conformation for bound peptides. Proc. Natl Acad. Sci. USA 93:734.
4. Lee, K. H., Wucherpfennig, K. W. and Wiley, D. C. 2001. Structure of a human insulin peptide-HLA-DQ8 complex and susceptibility to type 1 diabetes. Nat. Immunol. 2:501.
5. Pieters, J. 1997. MHC class II restricted antigen presentation. Curr. Opin. Immunol. 9:89.
6. Falk, K., Rotzschke, O., Stevanovic, S., Jung, G. and Rammensee, H. G. 1994. Pool sequencing of natural HLA-DR, DQ, and DP ligands reveals detailed peptide motifs, constraints of processing, and general rules. Immunogenetics 39:230.
7. Rammensee, H. G., Friede, T. and Stevanoviic, S. 1995. MHC ligands and peptide motifs: first listing. Immunogenetics 41:178.
8. Signorelli, K. L., Watts, L. M. and Lambert, L. E. 1995. The importance of DR4Dw4 beta chain residues 70, 71, and 86 in peptide binding and T cell recognition. Cell. Immunol. 162:217.
9. Fu, X. T., Bono, C. P., Woulfe, S. L., Swearingen, C., Summers, N. L., Sinigaglia, F., Sette, A., Schwartz, B. D. and Karr, R. W. 1995. Pocket 4 of the HLA-DR(alpha, beta 1*0401) molecule is a major determinant of T cells recognition of peptide. J. Exp. Med. 181:915.
10. Karr, R. W., Panina-Bordignon, P., Yu, W. Y. and Lanzavecchia, A. 1991. Antigen-specific T cells with monogamous or promiscuous restriction patterns are sensitive to different HLA-DR beta chain substitutions. J. Immunol. 146:4242.
11. Wang, W., Man, S., Gulden, P. H., Hunt, D. F. and Engelhard, V. H. 1998. Class I-restricted alloreactive cytotoxic T lymphocytes recognize a complex array of specific MHC-associated peptides. J. Immunol. 160:1091.
12. Rudolph, M. G., Huang, M., Teyton, L. and Wilson, I. A. 2001. Crystal structure of an isolated V(alpha) domain of the 2C T-cell receptor. J. Mol. Biol. 314:1.
13. Hennecke, J., Carfi, A. and Wiley, D. C. 2000. Structure of a covalently stabilized complex of a human alphabeta T-cell receptor, influenza HA peptide and MHC class II molecule, HLA-DR1. EMBO J. 19:5611.
14. Kwok, W. W., Nepom, G. T. and Raymond, F. C. 1995. HLA-DQ polymorphisms are highly selective for peptide binding interactions. J. Immunol. 155:2468.
15. Nepom, B. S., Nepom, G. T., Coleman, M. and Kwok, W. W. 1996. Critical contribution of beta chain residue 57 in peptide binding ability of both HLA-DR and -DQ molecules. Proc. Natl Acad. Sci. USA 93:7202.
16. Khalil-Daher, I., Boisgerault, F., Feugeas, J. P., Tieng, V., Toubert, A. and Charron, D. 1998. Naturally processed peptides from HLA-DQ7 (alpha1*0501-beta1*0301): influence of both alpha and beta chain polymorphism in the HLA-DQ peptide binding specificity. Eur. J. Immunol. 28:3840.
17. Wu, S. and Gorski, J. 1997. Polymorphism at β85 and not β86 of HLA-DR1 is predominantly responsible for restricting the nature of the anchor side chain: implication for concerted effects of class II MHC polymorphism. Int. Immunol. 9:1495.
18. Zeliszewski, D., Golvano, J. J., Gaudebout, P., Dorval, I., Freidel, C., Gebuhrer, L., Betuel, H., Borras-Cuesta, F. and Sterkers, G. 1993. Implication of HLA-DR residues at positions 67, 71, and 86 in interaction between HLA-DR11 and peptide HA306. J. Immunol. 151:6237.
19. L'Faqihi, F. E., Praud, C., Yassine-Diab, B., Enault, G., Lakhdar-Ghazal, F., de Preval, C. and Coppin, H. 1998. Residue 67 in the DRbeta1*0101 and DRbeta1*0103 chains strongly influences antigen presentation and DR-peptide molecular complex conformation. Tissue Antigens 51:10.
20. Verreck, F. A., van de, P. A., Termijtelen, A., Amons, R., Drijfhout, J. W. and Koning, F. 1994. Identification of an HLA-DQ2 peptide binding motif and HLA-DPw3-bound self-peptide by pool sequencing. Eur. J. Immunol. 24:375.
21. Chicz, R. M., Graziano, D. F., Trucco, M., Strominger, J. L. and Gorga, J. C. 1997. HLA-DP2: self peptide sequences and binding properties. J. Immunol. 159:4935.
22. Dong, R. P., Kamikawaji, N., Toida, N., Fujita, Y., Kimura, A. and Sasazuki, T. 1995. Characterization of T cell epitopes restricted by HLA-DP9 in streptococcal M12 protein. J. Immunol. 154:4536.
23. Urlacher, A., Dormoy, A. and Tongio, M. M. 1992. DP epitope mapping by using T-cell clones. Hum. Immunol. 35:100.
24. Gaston, J. S., Goodall, J. C., Young, J. L. and Young, S. P. 1997. Effect of polymorphism of the HLA-DPA1 chain on presentation of antigenic peptides. Hum. Immunol. 54:40.
25. Arroyo, J., Alvarez, A. M., Nombela, C. and Sanchez-Perez, M. 1995. The role of HLA-DP beta residue 69 in the definition of antibody-binding epitopes. Hum. Immunol. 43:219.
26. Diaz, G., Catalfamo, M., Coiras, M. T., Alvarez, A. M., Jaraquemada, D., Nombela, C., Sanchez-Perez, M. and Arroyo, J. 1998. HLA-DPbeta residue 69 plays a crucial role in allorecognition. Tissue Antigens 52:27.
27. Paul, C., Schoenwald, U., Truckenbrodt, H., Bettinotti, M. P., Brunnler, G., Keller, E., Nevinny-Stickel, C., Yao, Z. and Albert, E. D. 1993. HLA-DP/DR interaction in early onset pauciarticular juvenile chronic arthritis. Immunogenetics 37:442.
28. Begovich, A. B., Bugawan, T. L., Nepom, B. S., Klitz, W., Nepom, G. T. and Erlich, H. A. 1989. A specific HLA-DP beta allele is associated with pauciarticular juvenile rheumatoid arthritis but not adult rheumatoid arthritis. Proc. Natl Acad. Sci. USA 86:9489.
29. Richeldi, L., Sorrentino, R. and Saltini, C. 1993. HLA-DPB1 glutamate 69: a genetic marker of beryllium disease. Science 262:242.
30. Potolicchio, I., Festucci, A., Hausler, P. and Sorrentino, R. 1999. HLA-DP molecules bind cobalt: a possible explanation for the genetic association with hard metal disease. Eur. J. Immunol. 29:2140.
31. Amicosante, M., Sanarico, N., Berretta, F., Arroyo, J., Lombardi, G., Lechler, R., Colizzi, V. and Saltini, C. 2001. Beryllium binding to HLA-DP molecule carrying the marker of susceptibility to berylliosis glutamate beta 69. Hum. Immunol. 62:686.
32. Lombardi, G., Germain, C., Uren, J., Fiorillo, M. T., du Bois, R. M., Jones-Williams, W., Saltini, C., Sorrentino, R. and Lechler, R. 2001. HLA-DP allele-specific T cell responses to beryllium account for DP-associated susceptibility to chronic beryllium disease. J. Immunol. 166:3549.
33. Potolicchio, I., Brookes, P. A., Madrigal, A., Lechler, R. I. and Sorrentino, R. 1996. HLA-DPB1 mismatch at position 69 is associated with high helper T lymphocyte precursor frequencies in unrelated bone marrow transplant pairs. Transplantation 62:1347.
34. DeMars, R., Chang, C. C. and Rudersdorf, R. A. 1983. Dissection of the D-region of the human major histocompatibility complex by means of induced mutations in a lymphoblastoid cell line. Hum. Immunol. 8:123.
35. Royston, I., Omary, M. B. and Trowbridge, I. S. 1981. Monoclonal antibodies to a human T-cell antigen and Ia-like antigen in the characterization of lymphoid leukemia. Transplant Proc. 13:761.
36. Yu, W. Y., Watts, R. and Karr, R. W. 1990. Identification of amino acids in HLA-DPw4b beta and -DR5 beta 1 chains that are involved in antibody binding epitopes using site-directed mutagenesis and DNA-mediated gene transfer. Hum. Immunol. 27:122.
37. Marshall, W. H., Drover, S., Codner, D., Gamberg, J., Copp, M. D., Liu, H. W., Deng, L. T. and Younghusband, H. B. 1998. HLA-DP epitope typing using monoclonal antibodies. Hum. Immunol. 59:189.
38. Drover, S., Codner, D., Gamberg, J., Hutchings, L. and Marshall, W. H. 1991. A site-specific anti-HLA-DP monoclonal antibody recognizes molecules bearing 'DE' at positions 55 and 56 on the beta chain. Tissue Antigens 38:37.
39. Inoko, H., Bodmer, J. G., Heyes, J. M., Drover, S., Trowsdale, J. and Marshall, W. H. 1992. Join report of the transfectant monoclonal antibody component. In Tsuji, K., Akaza, T. and Sasazuki, T., eds, HLA 1991, p. 919. Oxford University Press, Oxford.
40. Biddison, W. E., Rao, P. E., Talle, M. A., Goldstein, G. and Shaw, S. 1984. Possible involvement of the T4 molecule in T cell recognition of class II HLA antigens. Evidence from studies of CTL-target cell binding. J. Exp. Med. 159:783.
41. Sanchez, P. M., Diez, O. R., Petersen, J. W., De Mars, R. and Shaw, S. 1990. Differences in specificity of 'DPw2-specific' cytotoxic T cell clones revealed with HLA-mutant lines: evidence that non-DP HLA genes influence recognition by some clones. Eur. J. Immunol. 20:673.
42. Dessen, A., Lawrence, C. M., Cupo, S., Zaller, D. M. and Wiley, D. C. 1997. X-ray crystal structure of HLA-DR4 (DRA*0101, DRB1*0401) complexed with a peptide from human collagen II. Immunity 7:473.
43. Ghosh, P., Amaya, M., Mellins, E. and Wiley, D. C. 1995. The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3. Nature 378:457.
44. Meyer, C. G., May, J. and Schnittger, L. 1997. HLA-DP - part of the concert. Immunol. Today 18:58.
45. Krieger, J. I., Karr, R. W., Grey, H. M., Yu, W. Y., O'Sullivan, D., Batovsky, L., Zheng, Z. L., Colon, S. M., Gaeta, F. C., Sidney, J. et al. 1991. Single amino acid changes in DR and antigen define residues critical for peptide-MHC binding and T cell recognition. J. Immunol. 146:2331.
46. Wang, J. H. and Reinherz, E. L. 2002. Structural basis of T cell recognition of peptides bound to MHC molecules. Mol. Immunol. 38:1039.
47. Demotz, S., Barbey, C., Corradin, G., Amoroso, A. and Lanzavecchia, A. 1993. The set of naturally processed peptides displayed by DR molecules is tuned by polymorphism of residue 86. Eur. J. Immunol. 23:425.
48. Johansen, B. H., Gjertsen, H. A., Vartdal, F., Buus, S., Thorsby, E., Lundin, K. E. and Sollid, L. M. 1996. Binding of peptides from the N-terminal region of alpha-gliadin to the celiac disease-associated HLA-DQ2 molecule assessed in biochemical and T cell assays. Clin. Immunol. Immunopathol. 79:288.
49. Chen, Y. Z., Matsushita, S. and Nishimura, Y. 1997. A single residue polymorphism at DR beta 37 affects recognition of peptides by T cells. Hum. Immunol. 54:30.
50. Wucherpfennig, K. W. 2001. Insights into autoimmunity gained from structural analysis of MHC-peptide complexes. Curr. Opin. Immunol. 13:650.
51. Reizis, B., Eisenstein, M., Mor, F. and Cohen, I. R. 1998. The peptide-binding strategy of the MHC class II I-A molecules. Immunol. Today 19:212.
52. Reinherz, E. L., Tan, K., Tang, L., Kern, P., Liu, J., Xiong, Y., Hussey, R. E., Smolyar, A., Hare, B., Zhang, R., Joachimiak, A., Chang, H. C., Wagner, G. and Wang, J. 1999. The crystal structure of a T cell receptor in complex with peptide and MHC class II. Science 286:1913.
53. Hennecke, J. and Wiley, D. C. 2002. Structure of a complex of the human alpha/beta T cell receptor (TCR) HA1.7, influenza hemagglutinin peptide, and major histocompatibility complex class II molecule, HLA-DR4 (DRA*0101 and DRB1*0401): insight into TCR cross-restriction and alloreactivity. J. Exp. Med. 195:571.
54. Rosen-Bronson, S., Yu, W. Y. and Karr, R. W. 1991. Polymorphic HLA-DR7 beta 1 chain residues that are involved in T cell allorecognition. J. Immunol. 146:4264.
55. Nicholson, I., Varney, M., Kanaan, C., Grigg, A., Szer, J., Tiedemann, K. and Tait, B. D. 1997. Alloresponses to HLA-DP detected in the primary MLR: correlation with a single amino acid difference. Hum. Immunol. 55:163.